Tanishta Bhattacharya

Tanishta Bhattacharya

Auto-generated profile, based on publicly available information

Tanishta Bhattacharya

Developmental Genetics (Dept III), Max Planck Institute for Heart and Lung Research

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Computers in Biology and Medicine
Verified
Journal Article
Open access
Sk Sarif HassanSk Sarif Hassan
Sk Sarif Hassan
TBTanishta Bhattacharya
Tanishta Bhattacharya
DNDebaleena Nawn
Debaleena Nawn
IJIshana Jha
Ishana Jha
PBPallab Basu
Pallab Basu
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the rapidly evolving RNA virus behind the COVID-19 pandemic, has spawned numerous variants since its 2019 emergence. The multifunctional Nonstructural protein 14 (NSP14) enzyme, possessing exonuclease and messenger RNA (mRNA) capping capabilities, serves as a key player. Notably, single and co-occurring mutations within NSP14 significantly influence replication fidelity and drive variant diversification. This study comprehensively examines 120 co-mutations, 68 unique mutations, and 160 conserved residues across NSP14 homologs, shedding light on their implications for phylogenetic patterns, pathogenicity, and residue interactions. Quantitative physicochemical analysis categorizes 3953 NSP14 variants into three clusters, revealing genetic diversity. This research underscoresthe dynamic nature of SARS-CoV-2 evolution, primarily governed by NSP14 mutations. Understanding these genetic dynamics provides valuable insights for therapeutic and vaccine development.
1

1 May 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
DNDebaleena Nawn
Debaleena Nawn
Sk Sarif HassanSk Sarif Hassan
Sk Sarif Hassan
ERElrashdy M. Redwan
Elrashdy M. Redwan
TBTanishta Bhattacharya
Tanishta Bhattacharya
PBPallab Basu
Pallab Basu
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky

11 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DNDebaleena Nawn
Debaleena Nawn
Sk Sarif HassanSk Sarif Hassan
Sk Sarif Hassan
Altijana Hromic-JahjefendicAltijana Hromic-Jahjefendic
Altijana Hromic-Jahjefendic
TBTanishta Bhattacharya
Tanishta Bhattacharya
PBPallab Basu
Pallab Basu
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
Background Melanoma, a worldwide widespread skin cancer with over 325,000 yearly incidences, demands a thorough understanding of its molecular components to create effective therapeutics. This study looks at the PRAME (cutaneous melanoma-associated antigen) and BAP1 (gene controlling gene-environment interactions) proteins, which are important in melanoma development and are important for understanding the molecular landscape of melanoma. Introduction While playing a crucial role in melanoma, the structural and functional characteristics of PRAME and BAP1 remain unidentified. This work tries to unravel their complexities by investigating conserved residues, sequence invariance, and other molecular characteristics that contribute to their importance in melanoma. Promising therapeutic targets for melanoma therapy are identified by analyzing these proteins at the molecular level. Methods The study makes extensive use of bioinformatics methods to analyze PRAME and BAP1, including sequence conservation, inherent disorder, polyglutamic acid presence, and polarity alterations. Established approaches are used to investigate residue changes and their effects on protein folding, aggregation, and interactions. Results PRAME and BAP1 conserved residues highlight their critical roles in protein function and interaction. Sequence invariance indicates the possibility of functional relevance and evolutionary conservation. In intrinsically disordered proteins (IDPRs), PRAME has enhanced intrinsic disorder and flexibility, whereas BAP1 has changed disorder-promoting residue sequences. Polyglutamic acid strings are found in both proteins, emphasizing their modulatory involvement in protein interactions. Protein folding and aggregation are influenced by polarity shifts, with a balanced distribution of acidic and basic residues preserving native structures. The ratios and distributions of amino acids, particularly neutral residues, have a profound influence on interactions and gene dysregulation. Conclusion PRAME and BAP1 structural and functional understanding pave the way for diagnostic and tailored treatment options in melanoma. Differences in residue alterations, polarity distributions, and amino acid ratios provide intriguing drug design options. This research contributes to a better knowledge of melanoma-associated two proteins, opening the path for novel diagnostic and therapy techniques in skin cancer and beyond.

28 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DNDebaleena Nawn
Debaleena Nawn
Sk Sarif HassanSk Sarif Hassan
Sk Sarif Hassan
ERElrashdy M. Redwan
Elrashdy M. Redwan
TBTanishta Bhattacharya
Tanishta Bhattacharya
PBPallab Basu
Pallab Basu
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky
Rare diseases, defined by their low prevalence, present significant challenges, including delayed detection, expensive treatments, and limited research. This study delves into the genetic basis of two noteworthy rare diseases in Saudi Arabia: Phenylketonuria (PKU) and Spinal Muscular Atrophy (SMA). PKU, resulting from mutations in the phenylalanine hydroxylase (PAH) gene, exhibits geographical variability and impacts intellectual abilities. SMA, characterized by motor neuron loss, is linked to mutations in the survival of motor neuron 1 (SMN1) gene. Recognizing the importance of unveiling signature genomics in rare diseases, we conducted a quantitative study on PAH and SMN1 proteins of multiple organisms by employing various quantitative techniques to assess genetic variations. The derived signature-genomics contributes to a deeper understanding of these critical genes, paving the way for enhanced diagnostics and treatments for disorders associated with PAH and SMN1.